Breast Ultrasound Market size exceeded USD 2.73 Billion in 2023 and is anticipated to cross USD 6.1 Billion by 2033, registering a CAGR of more than 7.7% during the forecast period.The breast ultrasound market is a subset of the medical imaging business that focuses on the creation, production, and distribution of ultrasound devices and technology that are especially suited for breast imaging and diagnostics.
High-frequency sound waves are used in breast ultrasonography, a non-invasive medical imaging procedure, to provide fine-grained images of the breast tissue. Breast ultrasonography is used for both diagnosis and breast cancer screening. It is especially useful for assessing breast anomalies discovered via routine mammography or clinical breast exams. The breast ultrasound market has expanded as a result of rising awareness of the value of early identification and screening for breast cancer. Campaigns for breast health awareness are frequently promoted by businesses, medical professionals, and advocacy groups.
Growth Drivers and Opportunities:
Increasing number of breast cancer cases across the world
The early identification of breast cancer is greatly aided by breast ultrasonography, particularly in those women with thick breast tissue. Small tumours that would not be seen on a mammography alone can be found using this test. Breast ultrasound is frequently used in addition to mammography for screening in high-risk individuals and as an additional tool for monitoring known breast abnormalities, such as cysts or tumours. Breast ultrasonography services are in increased demand as a result of growing awareness of the value of early identification and screening for breast cancer. Breast ultrasonography services are now more widely available thanks to the expansion of healthcare infrastructure in many areas.
Advancement in technology in the field of breast ultrasound systems
The resolution of breast ultrasound pictures has improved as a result of the introduction of high-frequency transducers and sophisticated imaging algorithms. This makes it possible to see tiny lesions and other abnormalities in the breast tissue more clearly. AI algorithms can help radiologists analyse breast ultrasound pictures, increasing diagnostic precision and efficacy. AI can assist in the detection and classification of anomalies, lowering the possibility of human mistake. Breast ultrasonography is now more widely available in a variety of healthcare settings, including remote or underserved places, thanks to the development of portable and handheld ultrasound machines. Breast ultrasound exams now follow a more efficient process, which also results in shorter wait times for patients.
Report Coverage | Details |
---|---|
Segments Covered | Product,End Use |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Alpinion Medical Systems Co., Ltd., BK Medical Holding Company, Inc., CANON MEDICAL SYSTEMS CORPORATION, FUJIFILM SonoSite, Inc., FUKUDA DENSHI, General electric company, Hitachi Aloka Medical, Ltd., Konica Minolta Healthcare Americas, Inc. Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Koninklijke Philips N.V., SAMSUNGHEALTHCARE.COM, Siemens, Sonoscanner, SonoScape Medical Corp, TELEMED Medical Systems, SonoCin., Trivitron Healthcare, Delphinus Medical Technologies, Inc., TechniScan Inc., Braster S.A. |
Industry Restraints & Challenges
Huge investment associated with the breast ultrasound system devices
It can be expensive to maintain and service modern breast ultrasound equipment beyond the initial purchase. This involves routine upkeep, updates, and repairs, which can put a strain on healthcare providers' resources. Advanced breast ultrasound devices require specialised training for healthcare workers to use them successfully. Healthcare establishments may have to spend a lot of money on employee training programmes and continuous education. The high upfront and continuing expenses associated with sophisticated devices may not always be sufficiently covered by reimbursement rates for breast ultrasonography operations in some areas. This may deter medical professionals from implementing these technology.
North American Market
North America is anticipated to dominate the Breast Ultrasound market through 2033. In North America, breast cancer is a common condition with high incidence rates among women. The need for breast imaging technologies, such as ultrasound, for screening, diagnosis, and monitoring has increased as a result. Medical technology innovation in North America is renowned. Because of this, the area frequently adopts and creates cutting-edge breast ultrasound technologies, such as sophisticated imaging methods and AI-driven solutions. A wide variety of ultrasound equipment and solutions are offered by multiple manufacturers and providers in the competitive North American breast ultrasound market. In the region, there are both major international providers of medical imaging services and more niche, smaller businesses.
Asia Pacific Market
Asia Pacific is witnessing the fastest market growth between 2024 to 2033. The region's huge and diversified population as well as rising healthcare costs are the main drivers of this increase. Many APAC nations are facing an increase in breast cancer cases, particularly in China and India, where the disease is becoming more common. As a result, there is now greater need for ultrasonography and other breast cancer detection technologies. Significant improvements in medical technology and imaging, such as breast ultrasonography, have been made in the APAC area. Modern ultrasound systems are frequently released by manufacturers in this sector to satisfy the growing need for better diagnostic capabilities. For specific patient populations, such as women with thick breast tissue, some APAC nations have developed national breast cancer screening programmes that use breast ultrasonography.
Insights by Product
The automated breast ultrasound segment accounted for the largest market share over the forecast period 2024 to 2033. Compared to conventional hand-held ultrasound, ABUS devices offer higher rates of breast cancer detection because they produce detailed, high-resolution images of the entire breast. For women with dense breast tissue, where mammography alone may be less effective, this feature is very helpful. There has been a rising demand for additional imaging modalities like ABUS as knowledge of mammography's limits in detecting breast cancer in women with dense breast tissue has grown. The prevalence of breast cancer is on the rise worldwide, and there is now more focus on early diagnosis, which frequently entails additional imaging using tools like ABUS.
Insights by End Use
The hospitals segment is expected the dominate the market over the forecast period 2024 to 2033. Comprehensive breast care services, such as breast cancer screening, diagnosis, surgery, and therapy, are frequently offered by hospitals. Breast ultrasound is a crucial element of these services, which supports the expansion of this market. For patients to have access to cutting-edge technology and high-quality imaging, hospitals must invest in state-of-the-art breast ultrasound equipment. Hospitals have the funds and infrastructure to do this. Dedicated breast cancer centres with specialised care and breast imaging services have been developed in numerous hospitals. In these facilities, breast ultrasonography is frequently a crucial element.
Major players in the market